Showing results (1-10 of 13) with videos related to
Sort By:
Pageof 2
Immunometabolism|June 4, 2021
Vascular Metabolism as Driver of Atherosclerosis: Linking Endothelial Metabolism to InflammationKim E Dzobo, Katie M L Hanford, Jeffrey KroonSTAR Protocols|January 12, 2025
Protocol to generate a 3D atherogenesis-on-chip model for studying endothelial-macrophage crosstalk in atherogenesisKatie M L Hanford, Kim E Dzobo, Miranda Versloot, et al.Atherosclerosis|May 24, 2020
Surmounting the endothelial barrier for delivery of drugs and imaging tracersJohan G Schnitzler, Kim E Dzobo, Nick S Nurmohamed, et al.Atherosclerosis|May 23, 2022
Lipoprotein(a): An underestimated inflammatory mastermindKim E Dzobo, Jordan M Kraaijenhof, Erik S G Stroes, et al.Current Opinion in Lipidology|October 7, 2020
Targeting epigenetics as atherosclerosis treatment: an updated viewAnnette E Neele, Lisa Willemsen, Hung-Jen Chen, et al.European Heart Journal Open|April 3, 2026
Reduced postprandial lipid accumulation in circulating monocytes by olezarsen attenuates pro-inflammatory changes in hypertriglyceridemic patientsMerel C Peletier, Jordan M Kraaijenhof, Miranda Versloot, et al.Atherosclerosis|August 17, 2024
Plasma C-reactive protein is associated with a pro-inflammatory and adverse plaque phenotypeJordan M Kraaijenhof, Barend M Mol, Nick S Nurmohamed, et al.Atherosclerosis|May 12, 2025
Accelerated atherosclerosis associated with immune checkpoint inhibitors: a systematic review and meta-analysis of pre-clinical studiesAnniek Strijdhorst, Winnie G Vos, Laura A Bosmans, et al.Atherosclerosis|February 3, 2022
Reduced baroreflex sensitivity and increased splenic activity in patients with severe obstructive sleep apneaYannick Kaiser, Kim E Dzobo, Madeline J L Ravesloot, et al.Clinical Epigenetics|November 11, 2020
BET protein inhibitor apabetalone (RVX-208) suppresses pro-inflammatory hyper-activation of monocytes from patients with cardiovascular disease and type 2 diabetesSylwia Wasiak, Kim E Dzobo, Brooke D Rakai, et al.Pageof 2